Skip to main content

Table 5 Association between separate endpoints survival and groups which divided by TyG in patients with plaque erosion

From: Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study

  Crude model Adjust model I Adjust model II Adjust model III
Group crude HR(95%CI) crude P value Adj I. HR(95%CI) Adj. P value Adj II. HR(95%CI) Adj. P value Adj III. HR(95%CI) Adj. P value
MACE         
 1 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
 2 0.20 (0.02,1.74) 0.146 0.12 (0.01,1.70) 0.118 0.69 (0.0,741.76) 0.916 0.09 (0.00,4.23) 0.218
 3 0.19 (0.02,1.62) 0.128 0.13 (0.01,1.18) 0.070 0.07 (0.00,1.79) 0.106 0.02 (0.00,0.91) 0.045*
 Trend test 0.37 (0.12,1.13) 0.080 0.30 (0.09,1.01) 0.051 0.26 (0.05,1.28) 0.097 0.14 (0.02,0.92) 0.041*
Revascularization         
 1 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
 2 0.76 (0.17,3.40) 0.718 0.75 (0.17,3.37) 0.705 0.77 (0.13,4.67) 0.777 0.73 (0.11,4.71) 0.737
 3 1.21 (0.32,4.51) 0.778 1.24 (0.32,4.71) 0.756 0.98 (0.23,4.11) 0.979 0.93 (0.21,4.12) 0.922
 Trend test 1.11 (0.56,2.23) 0.761 1.13 (0.56,2.28) 0.742 0.99 (0.48,2.05) 0.975 0.97 (0.45,2.07) 0.933
Angina         
 1 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
 2 0.51 (0.09,2.76) 0.431 0.41 (0.08,2.27) 0.309 0.37 (0.04,3.08) 0.357 0.29 (0.03,3.06) 0.304
 3 0.49 (0.09,2.67) 0.408 0.38 (0.07,2.13) 0.274 0.19 (0.02,1.73) 0.140 0.19 (0.01,2.42) 0.201
 Trend test 0.68 (0.28,1.62) 0.380 0.59 (0.24,1.45) 0.250 0.42 (0.14,1.27) 0.125 0.41 (0.12,1.43) 0.163
Bleeding events         
 1 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
 2 1.45 (0.72,2.92) 0.295 1.43 (0.71,2.89) 0.313 1.42 (0.63,3.23) 0.397 1.46 (0.63,3.39) 0.379
 3 1.80 (0.93,3.50) 0.083 1.75 (0.89,3.41) 0.102 2.16 (1.00,4.67) 0.049* 2.50 (1.11,5.65) 0.028*
 Trend test 1.33 (0.96,1.85) 0.083 1.31 (0.95,1.82) 0.103 1.47 (1.00,2.16) 0.047* 1.59 (1.06,2.39) 0.027*
  1. Data presented are HRs and 95% CI. Adjust I model adjusts for sex and age; Adjust II model adjusts for adjust I plus ejection fraction, smoke, hypertension, hyperlipidemia, diabetes mellitus; Adjust III model adjusts for adjust II + creatine kinase, heart rate and C-reactive protain
  2. Adj., adjusted; MACE, major adverse cardiovascular events; HR, hazard ratio; CI, confidence interval
  3. *P < 0.05